Patent · US Active

Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma

US9446099B2 · kind B2 · utility

2Cited by

1References

4Claims

0Family size

Assignees

DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS · DE
RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

Irina Kiprijanova · Heidelberg, DE
Manuel Fischer · Neufra, DE
Jean Rommelaere · Heidelberg, DE
Joerg Schlehofer · Leimen, DE
Karsten Geletneky · Heidelberg, DE

Key dates

Filing date	May 19, 2010
Grant date	Sep 20, 2016
Priority date	—
Expiry date	May 19, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14371
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a pharmaceutical composition comprising (a) a parvovirus and (b) a cytokine, preferably IFN-γ, and the use of said composition for treatment of cancer, e.g., a brain tumor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.